PLGA CAS 26780-50-7

PLGA (CAS 26780-50-7): Comprehensive User Guide for Procurement and Applications

Table of Contents

• 1. PLGA Basic Properties & Specifications
• 2. PLGA Applications in Pharmaceutical and Medical Industries
• 3. Technical Comparison: PLGA 50/50 vs 75/25 vs 85/15
• 4. Case Studies: Successful Implementations of PLGA
• 5. How to Select the Right PLGA for Your Project
• 6. Industry-Leading Suppliers & Procurement Guidance

1. PLGA Basic Properties & Specifications

2. PLGA Applications in Pharmaceutical and Medical Industries

2.1 Drug Delivery Systems

PLGA nanoparticles enable controlled release of:

• Chemotherapeutic agents (e.g., Paclitaxel)
• Protein-based therapeutics
• Vaccine antigens

2.2 Medical Devices

FDA-approved applications include:

• Absorbable sutures
• Bone fixation devices
• Dental membranes

3. Technical Comparison: PLGA Ratios

4. Case Studies: Successful Implementations of PLGA

Case 1: Oncology Drug Delivery (2023)

Client: European Pharma Co., Ltd.
Application: Doxorubicin-loaded PLGA nanoparticles
Results: 60% reduction in systemic toxicity, 3x tumor accumulation

Case 2: Regenerative Medicine (2024)

Client: MedTech Solutions Inc.
Application: PLGA scaffolds for bone regeneration
Results: 85% osteoblast adhesion rate, 12-week complete degradation

5. Selection Guide for PLGA Grades

• Molecular Weight: 7,000-200,000 Da options
• End-group Modification: Carboxyl vs. ester terminated
• Sterilization Compatibility: Gamma vs. ETO methods

6. Supplier Evaluation & Procurement Process

Key quality parameters to verify:

1. Residual monomer content (<1%)
2. Molecular weight distribution (PDI <1.7)
3. GMP certification status

Request Custom PLGA Solutions

Contact our material science team:
Email: info@vivalr.com
Phone: (86) 15866781826